3072 related articles for article (PubMed ID: 32778143)
21. Ferroptosis, Necroptosis, and Pyroptosis in Gastrointestinal Cancers: The Chief Culprits of Tumor Progression and Drug Resistance.
Zhu X; Li S
Adv Sci (Weinh); 2023 Sep; 10(26):e2300824. PubMed ID: 37436087
[TBL] [Abstract][Full Text] [Related]
22. Targeting novel regulated cell death: Ferroptosis, pyroptosis and necroptosis in anti-PD-1/PD-L1 cancer immunotherapy.
Yu L; Huang K; Liao Y; Wang L; Sethi G; Ma Z
Cell Prolif; 2024 Apr; ():e13644. PubMed ID: 38594879
[TBL] [Abstract][Full Text] [Related]
23. Death and fire-the concept of necroinflammation.
Linkermann A
Cell Death Differ; 2019 Jan; 26(1):1-3. PubMed ID: 30470796
[No Abstract] [Full Text] [Related]
24. Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer.
Zhang C; Liu N
Front Immunol; 2022; 13():920059. PubMed ID: 35958626
[TBL] [Abstract][Full Text] [Related]
25. Harnessing Pyroptosis for Cancer Immunotherapy.
Bourne CM; Taabazuing CY
Cells; 2024 Feb; 13(4):. PubMed ID: 38391959
[TBL] [Abstract][Full Text] [Related]
26. Cell Death Pathway Regulation by Functional Nanomedicines for Robust Antitumor Immunity.
Li Y; Guo Y; Zhang K; Zhu R; Chen X; Zhang Z; Yang W
Adv Sci (Weinh); 2024 Jan; 11(3):e2306580. PubMed ID: 37984863
[TBL] [Abstract][Full Text] [Related]
27. TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis.
Jiang Z; Lim SO; Yan M; Hsu JL; Yao J; Wei Y; Chang SS; Yamaguchi H; Lee HH; Ke B; Hsu JM; Chan LC; Hortobagyi GN; Yang L; Lin C; Yu D; Hung MC
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33855973
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory cell death induced by cytotoxic lymphocytes: a dangerous but necessary liaison.
de Miguel D; Ramirez-Labrada A; Uranga I; Hidalgo S; Santiago L; Galvez EM; Arias M; Pardo J
FEBS J; 2022 Aug; 289(15):4398-4415. PubMed ID: 34174027
[TBL] [Abstract][Full Text] [Related]
29. Identification of ferroptosis, necroptosis, and pyroptosis-associated genes in periodontitis-affected human periodontal tissue using integrated bioinformatic analysis.
Pan S; Li Y; He H; Cheng S; Li J; Pathak JL
Front Pharmacol; 2022; 13():1098851. PubMed ID: 36686646
[No Abstract] [Full Text] [Related]
30. Arsenic trioxide elicits prophylactic and therapeutic immune responses against solid tumors by inducing necroptosis and ferroptosis.
Chen J; Jin Z; Zhang S; Zhang X; Li P; Yang H; Ma Y
Cell Mol Immunol; 2023 Jan; 20(1):51-64. PubMed ID: 36447031
[TBL] [Abstract][Full Text] [Related]
31. Comparing the effects of different cell death programs in tumor progression and immunotherapy.
Messmer MN; Snyder AG; Oberst A
Cell Death Differ; 2019 Jan; 26(1):115-129. PubMed ID: 30341424
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of ferroptosis in cancer: a matter of context?
Catanzaro E; Demuynck R; Naessens F; Galluzzi L; Krysko DV
Trends Cancer; 2024 May; 10(5):407-416. PubMed ID: 38368244
[TBL] [Abstract][Full Text] [Related]
33. Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosis.
Erkes DA; Cai W; Sanchez IM; Purwin TJ; Rogers C; Field CO; Berger AC; Hartsough EJ; Rodeck U; Alnemri ES; Aplin AE
Cancer Discov; 2020 Feb; 10(2):254-269. PubMed ID: 31796433
[TBL] [Abstract][Full Text] [Related]
34. The emerging roles of nitric oxide in ferroptosis and pyroptosis of tumor cells.
He Q; Qu M; Xu C; Shi W; Hussain M; Jin G; Zhu H; Zeng LH; Wu X
Life Sci; 2022 Feb; 290():120257. PubMed ID: 34952041
[TBL] [Abstract][Full Text] [Related]
35. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
[TBL] [Abstract][Full Text] [Related]
36. Targeting non-apoptotic cell death in cancer treatment by nanomaterials: Recent advances and future outlook.
Sepand MR; Ranjbar S; Kempson IM; Akbariani M; Muganda WCA; Müller M; Ghahremani MH; Raoufi M
Nanomedicine; 2020 Oct; 29():102243. PubMed ID: 32623018
[TBL] [Abstract][Full Text] [Related]
37. CD8
Wang W; Green M; Choi JE; Gijón M; Kennedy PD; Johnson JK; Liao P; Lang X; Kryczek I; Sell A; Xia H; Zhou J; Li G; Li J; Li W; Wei S; Vatan L; Zhang H; Szeliga W; Gu W; Liu R; Lawrence TS; Lamb C; Tanno Y; Cieslik M; Stone E; Georgiou G; Chan TA; Chinnaiyan A; Zou W
Nature; 2019 May; 569(7755):270-274. PubMed ID: 31043744
[TBL] [Abstract][Full Text] [Related]
38. Programmed cell death in tumor immunity: mechanistic insights and clinical implications.
Wang M; Yu F; Zhang Y; Li P
Front Immunol; 2023; 14():1309635. PubMed ID: 38283351
[TBL] [Abstract][Full Text] [Related]
39. Programmed necrotic cell death of macrophages: Focus on pyroptosis, necroptosis, and parthanatos.
Robinson N; Ganesan R; Hegedűs C; Kovács K; Kufer TA; Virág L
Redox Biol; 2019 Sep; 26():101239. PubMed ID: 31212216
[TBL] [Abstract][Full Text] [Related]
40. The role of ferroptosis in melanoma.
Talty R; Bosenberg M
Pigment Cell Melanoma Res; 2022 Jan; 35(1):18-25. PubMed ID: 34407291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
